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Neuromodulation is a new therapeutic pathway to treat inflammatory conditions by mod-
ulating the electrical signalling pattern of the autonomic connections to the spleen. However,
targeting this sub-division of the nervous system presents specific challenges in translating
nerve stimulation parameters. Firstly, autonomic nerves are typically embedded non-
uniformly among visceral and connective tissues with complex interfacing requirements.
Secondly, these nerves contain axons with populations of varying phenotypes leading to
complexities for axon engagement and activation. Thirdly, clinical translational of meth-
odologies attained using preclinical animal models are limited due to heterogeneity of the
intra- and inter-species comparative anatomy and physiology. Here we demonstrate how this
can be accomplished by the use of in silico modelling of target anatomy, and validation of
these estimations through ex vivo human tissue electrophysiology studies. Neuroelectrical
models are developed to address the challenges in translation of parameters, which provides
strong input criteria for device design and dose selection prior to a first-in-human trial.
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Neuromodulation using active implantable medical devicesis a promising new therapeutic avenue for a number ofdisease indications focussing on chronic inflammation1–3;
the premise being to selectively modulate autonomic nerves fas-
cicles supplying internal organs that they innervate. This tech-
nique has a great potential for treating various patient
populations which are refractory to traditional pharmacological,
or biological treatments.
Devices that harness electrical impulses to treat diseases are
already widely used, originating with cardiac pacemakers over 50
years ago, and more recently expanding into the central nervous
system with deep-brain stimulators and spinal cord stimulators
for indications such as Parkinson’s disease4,5 and chronic pain6–8.
More recently neuromodulation opportunities have leveraged the
selectivity and reduced invasiveness of the peripheral nervous
system stimulation such as neuromodulation of the sacral nerves
for bladder control9–11. Over the past twenty years, autonomic
neuromodulation of the vagus nerve trunk has opened a treat-
ment opportunity for refractory epilepsy12,13, depression14,15, and
more recently rheumatoid arthritis (RA) and inflammatory Bowel
Disease5,6,16–19. In a recent clinical trial in RA patients from the
company Setpoint Medical, stimulation of the vagus nerve for up
to four times daily inhibited the production of the proin-
flammatory cytokine tumour necrosis factor alpha (TNFα) and
significantly improved RA disease severity19. The mechanism of
action of this anti-inflammatory activity is proposed to be
through targeting of the cholinergic anti-inflammatory path-
way16, involving the efferent vagus connections to the coeliac
ganglion, which in turn activates splenic nerves to cause the anti-
inflammatory effect with monocytes of the spleen. However, sti-
mulation of the vagus nerve can often result in undesired phy-
siological side effects. Direct vagal innervation of the heart can
lead to bradycardia and asystole20–22 and proximity of motor
nerves in the neck can lead to cough, hoarseness, voice alteration
and paresthesias23,24. Central nervous system side effects
including nausea, anxiety, and headache25,26 are additional risk
factors due to afferent pathways to the brainstem. More recently,
pre-clinical research is building evidence of expansion for bioe-
lectronic modulation of nerves closer to the target organs that
have been shown in areas such as ovarian27, carotid sinus nerve28,
greater splanchnic nerve29, and splenic nerves30,31. In line with
this, Galvani Bioelectronics has recently sponsored a clinical trial
to demonstrate the clinical feasibility and safety of splenic neu-
romodulation during minimally invasive surgery for oesophageal
cancer to assess impact on the inflammatory response32. During
this procedure, a stimulation lead will be placed on the exposed
splenic neurovascular bundle and stimulation will be applied to
evaluate nerve activation.
Prior to clinical applications in humans, the biological effects of
peripheral nerve stimulation on the target region and organs are
typically assessed in pre-clinical rodent models. The anatomical
sites in these pre-clinical models, however, are several folds
smaller than in humans. For example, the diameter of the vagus
nerve in rats is a single 0.4 mm fascicle vs a multi-fascicle 2 mm
diameter nerve in humans33. This provides little insight into
appropriate levels of dose, or charge requirements in the clinical
setting, let alone the correct anatomical requirements for device
design. A large animal model (porcine or canine) is, therefore,
often used to verify safety and appropriateness of therapy and
implant design. However, even in large animal models, inference
and extrapolation are usually necessary to translate parameters to
human tissue for regulatory approval. Moreover, while large
animal models can replicate some of the anatomical variations
also seen in humans, they may fall short of accurately modelling
variations in human patients arising from differences in age,
body-mass index, natural micro- and macro-anatomical variance,
or co-morbidities. To further de-risk clinical studies and establish
more appropriate product designs, it is therefore, valuable to
confirm that the stimulation parameters identified in animal
models translate safely and efficaciously to humans prior to
clinical application34–36.
Here we applied two complementary approaches to address
these challenges in a novel translational anatomy of the human
splenic neurovascular bundles to determine the estimations of
stimulation parameters for activating the human splenic neuro-
vascular bundle. Recent work has provided evidence that stimu-
lation of the splenic nerve in large animal translational models
results in a robust inhibition of induced inflammation [Donegà
et al. (manuscript under review)] and is currently being developed
as a therapy for humans32.
Firstly, we used histomorphometric estimations from pig and
human splenic tissue to design and build representative neuroe-
lectrical computational models for nerve activation through
extra-neurovascular cuff electrodes37–42. While computational
modelling is relatively recent in the field of neuromodulation, it
has already been successfully utilised in several neural engineering
applications. For example, a Finite Element Method (FEM) of a
compound peripheral nerve describes the dependence of activa-
tion threshold on conductivity of perineurium and endoneur-
ium41,43. Stimulation parameters on the vagus nerve have also
been estimated through computational modelling43. In this work,
we conducted a simulation study representing approximated
nerve behaviour. We used multiple neurostimulation scenarios to
determine stimulation current-, charge- and charge-density
requirements for nerve recruitment in porcine and human sple-
nic neurovascular bundle (SNVB). We then validated our mod-
elling data by measuring electrophysiological parameters in
freshly explanted human splenic neurovascular bundle obtained
from organ transplant donors after ethical approval and informed
consent. We stimulated the explanted SNVB in an ex vivo elec-
trophysiology preparation using a bipolar cuff electrode and
recorded the stimulation-evoked compound action potentials
(eCAPs) using downstream hook electrodes. These two approa-
ches have enabled the determination of clinical relevant stimu-
lation parameters for implantable device requirements for human
use while refining and confirming the electrode configurations for
this therapeutic intervention. Improved characterisation of the
relationship between stimulation parameters and nerve recruit-
ment is important for development of neuromodulation thera-
pies44, to ensure efficacy and safety of proposed stimulation
parameters before first-in-human trials45.
Results
Histomorphometric characterisation of human and porcine
splenic anatomy. The first objective of this study was to develop
an understanding of human and porcine splenic anatomy and
estimate the dimensions of the tissue elements in humans and
pigs using histological techniques. For this we obtained six
samples of SNVB from both humans and pigs. The pig tissue was
obtained from farm pigs (45–60 kg body weight—Large White/
British Landrace cross) in accordance with the UK Animal (Sci-
entific Procedures) Act 1986. Human tissue was obtained from
transplant organ donors after ethical approval and informed
consent and transported at 4 °C in UW (University of Wisconsin)
organ preservation solution. The tissue in both cases was
immersed and fixed in 10% neutral buffered formalin (NBF) as
soon as possible post-excision. The details of age, gender, body
mass index, post-mortem intervals and tissue quality are provided
in Supplementary Table 1. The post-mortem interval for human
samples was in the range of ~12–40 h.
The samples were divided into sequential blocks for histology
(see Fig. 1b, Methods—Histology). The blocks were embedded in
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paraffin, sectioned and stained with haematoxylin and eosin
(H&E) (see Fig. 1c, d). All tissue sections were then examined by
a histopathologist and glass slides were scanned. Tissue shrinkage
due to fixation was roughly estimated at 10–20% based on
previous reports in literature46,47. The artery diameter is
representative of diastolic arterial pressure. Subsequently, the
slides were analysed for histomorphometric estimations accord-
ing to the methodology presented in Fig. 1b. For quantification
purposes, the splenic tissue was divided into three parts i.e.
proximal (close to aorta), middle (target location for interface)
and distal (close to spleen), as shown in Fig. 1b. For splenic
neuromodulation, the target location for interface were approxi-
mately the middle region of the splenic artery. The quantification
for this part is described in the next paragraph for the purpose of
building the computational model. In depth characterisation of
histomorphometric results including proximal and distal regions
are presented in a separate publication [Donegà et al. (manuscript
under review)].
In this middle location, for pig, mean Feret fascicle diameter,
internal and external splenic artery diameters were estimated to
be in the range of approximately 50–250 μm, 0.8–1 mm and
1.5–2.2 mm respectively (see Fig. 1c, Supplementary
Fig. 1) [Donegà et al. (manuscript under review)]. In contrast,
for humans, middle splenic artery diameter (internal+ external)
was found to be much bigger, in the range of ~4–6 mm. Fascicle
diameter was in the range of 20–400 μm similar to pigs (Fig. 1d,
Supplementary Fig. 2).
We next estimated the fascicle spread, i.e. distance away from
the tunica adventitia. In pigs, the fascicles were more evenly
distributed around the circumference of the artery and in close
proximity (<500 μm), whereas in humans, approximately 50%
were found in 0–1mm region, 30% in 1–2 mm, 15% in 2–3 mm
and the remaining in about 3–4 mm circumferential region
around the artery (Fig. 1c, d, Supplementary Figs. 1, 2). The
diameter of the neurovascular bundle (splenic artery diameter +
fascicle spread) in humans can thus vary between 6–10 mm
approximately (Supplementary Table 2). Substantially more
adipose tissue was noted in all the human samples compared to
the pig, and some fascicles were also found to be buried in this
adipose tissue. It should also be noted that the relative location of
fascicles in the loose connective tissue is likely to be affected by
post-mortem tissue changes. In particular fat is poorly preserved
in formalin-fixed tissues due to dehydration, thus, positions and
measurements described herein can only be an approximation of
the in vivo scenario.
Finally, a cross section of human SNVB fixed in 10% NBF was
examined by Transmission Electron Microscopy (TEM), as
shown in Fig. 1e (Methods – Transmission Electron Microscopy).
Analysis of images of nerve fascicles showed axon diameters to be
in the range of 0.5–1 μm and confirmed the composition to be
mainly unmyelinated (Supplementary Fig. 3, approx. >99%). A
low magnification image of a large nerve fascicle is also shown in
Supplementary Fig. 4 to confirm the composition of the target to
be mainly unmyelinated.
Simulated charge requirements from porcine to human splenic
neurovascular bundle. The electrical stimulation of neurovas-
cular bundles, comprising a loose network of C-fibres represents a
novel and significant challenge in bioelectronic medicine. Somatic
peripheral nerves contain fascicles that are tightly bound, coa-
lesced, and double-insulated by perineurium and epineurium,
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Fig. 1 Histomorphometric characterisation of human and pig splenic anatomy. a Anatomical sketch visualising the splenic artery branching from the aorta
via coeliac trunk and running to the spleen. A peri-arterial cuff is placed around the mid splenic artery indicated in yellow. b Quantification of the
histological sections; measurements include distance of the fascicle from adventitia, vessel lumen diameter, splenic artery and fascicle diameter (fascicle
diameter was determined using minimum Feret diameter). The sub-image indicates the trimming scheme used to obtain tissue sections of the artery. c, d
Example of porcine and human H&E histology sections. The U-shaped arc represents the artery and nerves which are placed under the cuff, and black
circles highlight individual fascicles. e Transmission electron microscopy image of axons within a nerve fascicle used to estimate axon diameter. A
myelinated axon is indicated with an asterisk (*); an unmyelinated axon is indicated with an (+).
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and the axons of interest are typically lower threshold (myeli-
nated A-fibres). Conversely, the bundle of individual fascicles in
SNVB are randomly arranged around the splenic artery, sur-
rounded by connective and adipose tissue (varying in pigs and
humans), and include fibres that are mostly unmyelinated C-
fibres. Evidence of this can be seen in the histology images in
Fig. 1, Supplementary Figs. 3 and 4.
Hybrid electromagnetic (EM) and neuronal simulations
combining methods of computational electromagnetics and
neuroscience are widely used tools used in support of
bioelectronic medicine. They were used in this work to predict
recruitment of small (0.5 μm) and large (1 μm) unmyelinated C-
fibres in two representative image-based and 3D computational
neurostimulation models of human and porcine SNVB. Multiple
variations of dielectric parameters of the nerve bundles and
several stimulus pulse shape (charge balanced biphasic pulses; 0.4
ms, 1 ms or 2 ms per phase) were examined. The two chosen fibre
diameters delineate the statistical range of measured C-fibre
diameters. Therefore, our modelling work aims at characterising
the extreme stimulation conditions instead of a single detailed
scenario. The underlying motive of the study was to computa-
tionally assess the principal neurostimulation differences between
the two species in order to translate the effective stimulation
conditions from pig to human for clinical application.
Details of the modelling pipeline are described in the ‘Methods’
section. Supplementary Fig. 5 also demonstrates a flow chart to
describe the stepwise approach followed to build computational
simulations. In summary, one representative cross section
histological image of SNVBs for each species (see Fig. 2a, b)
was segmented using iSEG48 within the Sim4Life platform48
(ZMT Zurich MedTech AG, Switzerland). Images of SNVB were
differentiated to identify tissue (connective/adipose), vessel wall,
blood, extra fascicular medium—internal and external to the
electrode—and the endoneurium tissue within fascicles (the
associated tissue properties can be found in ‘Methods—Dielectric
Properties of Tissue’). The segmented tissue surfaces were
extruded into 3D structures (‘Methods—Computational Model
Generation’). The SNVB models were combined with cuff
electrode geometries and surrounded by simulated saline solution
to mimic experimental conditions. Fascicles were populated with
multiple parallel axonal trajectories randomly distributed within
each fascicle cross section (Fig. 2, ‘Methods—Mesh Generation
and EM simulations, Population of Fascicles with Axon
Trajectories’).
In order to execute neuroelectric simulations the C-fibre Sundt
Model49 (‘Methods—C-fibre Electrophysiological Model’) was
implemented in Sim4Life. The model incorporates the function-
alities required to stimulate distributed unmyelinated C-fibres
arbitrary fibre diameters. Simulated electric-field distributions,
results of the EM simulations, were fed into the C-fibre models
scaled by the pulse shape to quantify the dynamic response of the
neuronal membrane to the transient stimulation. Ohmic-Current
Dominated solver with quasi-static condition was used for all the
tissues (‘Methods—Dielectric Properties of Tissues’). Titration
procedures were then used to quantify pulse-shape dependent
stimulation thresholds, as well as strength-duration (S-D), and
recruitment curves (‘Methods—Coupled EM and Neuronal
Simulations and Threshold Current Quantification’). Sensitivity
analyses, accounting for instance for variation in dielectric
properties of tissues or different pulse parameters were also
performed. The creation of neuroelectric models, setup of hybrid
EM-neuronal simulations and the post-processing of the results
was assisted by Python scripts (‘Methods—Data processing,
Sensitivity Analysis’).
For the porcine model, both a closed and split cuff (2.5 mm
diameter, 8 mm length, Cortec GmBH, Germany, Ref:
1041.2180.01 with a contact area of 2 × 6.5 mm2 50,51) were
modelled to also cover the in vivo situation where the electrode
coverage of the splenic neurovasculature can be around 70%
(Supplementary Fig. 6) [Donegà et al. (manuscript under
review)]. For the human model, a segmented periarterial cuff
was applied (Fig. 2i, ‘Methods—Cuff design’). The splits in the
cuff model and discontinuous electrode coverage represent the
surgical procedure during in vivo scenario.
For the porcine cuff electrode model with connective tissue on
the inside and saline on the outside, minimal threshold currents
for two pulse widths at two fibre diameters were identified.
Threshold currents in response to stimuli with a 0.4 ms pulse
width was between 5.5 and 9 mA for 1 and 0.5 µm fibre diameter
respectively. At 1 ms pulse width thresholds were 2.3 and 3.6 mA
respectively (closed electrode model). By increasing pulse widths,
the current needed for activation decreases potentially due to
neural accommodation and membrane potential stabilisation
induced by lengthy stimuli52. Full fascicle excitation was
estimated between 66.3 and 34.7 mA for 0.4 ms pulse width and
between 21.9 and 11.3 mA for 1 ms pulse width (see Fig. 2k for
0.5 μm results, Supplementary Fig. 7). When comparing porcine
in silico predicted (Fig. 2k) and recorded in vivo recruitment
curves (Supplementary Figs. 6b and 7) [Donegà et al. (manuscript
under review)], a good alignment was found with a less than
<10% difference in activation thresholds, supporting the suit-
ability of the FEM approach and appropriateness for use in
human electrophysiology modelling.
For the specific human cuff electrode model, the interfascicular
tissue was assigned the average dielectric properties of fat and
connective tissue with the region external to the electrode
assigned to saline dielectric properties (setup FCS). Threshold
currents in response to stimuli with a 0.4 s pulse width was
between 21.7 and 41 mA for 1 and 0.5 µm fibre diameter
respectively. At 1 ms pulse width thresholds were 7.7 and 14.1
mA respectively. 50% fibre recruitment was estimated between 25
and 48.2 mA for 1 ms pulse width and between 73.4 and 143 mA
for 0.4 ms pulse width (see Fig. 2l, Supplementary Fig. 8).
Thresholds above 200mA for 100% fibre recruitment were found
for all pulse widths and fibre diameters mainly due to dielectric
properties around the cuff opening (see Fig. 3, Supplementary
Fig. 9). Such hypothetical currents may result in safety and
feasibility relevant issues, for example, with electrochemical limits
of electrode materials and size of the implantable device.
Additional neurostimulation scenarios for human models were
also considered where the dielectric properties of the tissue inside
& outside the cuff were varied, as shown in Fig. 2m and Fig. 3. For
setup F (Fig. 3a), where only the dielectric properties of fat were
present both inside and outside the cuff, thresholds for the largest
diameter fibres of 1 μm at a pulse width of 1 ms are 2.8 mA.
When both fat and connective tissue were included on the inside
and outside the cuff (setup FC, Fig. 3b), this threshold increased
to 8.3 mA. With the area outside the cuff set to saline and the
inside to fat and connective tissue (setup FCS, Fig. 3c), the
threshold was 7.7 mA. These results suggest that the change in
conductivity within interfascicular tissue has a larger impact on
thresholds than the conductivity of the medium outside the
electrodes. Thresholds in setup F were three times lower than
Setup FCS whereas Setups FC and FCS only differed by 10%.
The fascicular location with respect to the electrode contacts
and the cuff openings for the human model - physical
dimensions, and large electrical conductivity of the structures
largely affect the electric field distribution and stimulation pattern
(Fig. 3 and Supplementary Figs. 9, 10). Electric field distributions
quickly drop radially from the internal surface of the electrode
towards the centre of the vessel and vary for different
composition of tissue dielectric properties. The decrease is
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Fig. 3 Electric field distribution in axial cross section centred on one electrode in the human model. The different images refer to the different
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substantial at the interface with the blood domain because of
dielectric discontinuity and within fascicles due to the presence of
the large insulating perineurium and large tissue anisotropy. The
cuff opening limits the exposure of the fascicles in this region to
the main E-field, not on principal current path, and therefore
resulting in considerable higher thresholds (Supplementary
Figs. 9, 10). Fascicles introduce heterogeneity in the intra-
electrode electrical field. Within the fascicles, the electric field is
much more homogenous due to shielding by the highly resistive
perineurium (Supplementary Fig. 9). A statistical analysis of the
activation thresholds within the different fascicles indicates that,
in the human model, the recruitment of fascicles in close
proximity to the cuff openings (away from the electrical contact
pads) requires approximately three times more current than that
of fibres in fascicles elsewhere (Supplementary Fig. 10). The
relative variability of threshold within fascicles was less than <8%.
Furthermore, charge duration curves for biphasic and mono-
phasic stimulations were derived for two different randomly
chosen fibres as shown in Fig. 2n to theoretically interpret the
relationship between 0.4 ms and 1 ms pulse widths. The
simulation indicates 1–3ms as appropriate for biphasic stimula-
tion of nerves in the human model. At such long pulse widths, the
charge required for activation for both monophasic and biphasic
stimulation is approximately equal53.
Modelling results suggest that bundle specific characteristics
such as the effect of the pulse width, axon diameter, cuff design
and interfascicular tissue medium are the principal factors
affecting recruitment curves and thresholds. Compared to the
effect of current-shunting through the cuff openings and the
effect of electrode-fascicle distance, the effect of tissue con-
ductivity outside the electrode is much lower51. The results
indicate that stimulation thresholds can be reduced by 3 times
with 2.5 times increase in pulse width (i.e., 0.4 ms to 1 ms). Thus,
the use of wider pulse widths (e.g., >1 ms) for clinical applications
can enable reduced current amplitude requirements in IPG
design. Current-mode based IPGs are used routinely for spinal
cord and deep brain stimulation applications, and provide
amplitude ranges of 1–16 mA54–58. Leveraging platform
methodology such as described here, early in the research process
can provide appropriate system-level requirement definition and
integrated circuit (IC) design, including analogue front-end
stimulation circuits and power modules.
Furthermore, a number of limitations should be taken into
consideration when interpreting the data from the computational
models. These include, (i) the uncertainty and variability
associated with the dielectric properties of tissues, (ii) potential
large anatomical inter-subject variability, (iii) variations in
electrode positioning versus fascicle positions and (iv) the use
of 2.5D simplified nerve geometry that does not represent the full
3D complexity in vivo. Lastly, this model does not consider the
activation of myelinated fibres as the SNVB primarily contains
unmyelinated fibres. Myelinated fibres have much lower activa-
tion thresholds and are likely to be maximally activated or even
blocked at the thresholds of unmyelinated fibres.
Electrophysiological characterisation of the human SNVB
(ex vivo). The final approach for identifying stimulation para-
meters in humans was to validate the simulated results using
ex vivo human SNVB samples. Figure 4a shows an example of
fresh splenic sample from a 63-year-old female donor. The
sample was placed in a petri dish, and the SNVB was then
carefully surgically-isolated from excess adipose tissue and the
splenic vein. A few nerve fascicles were carefully isolated distally
for the purpose of recording eCAPs. An isolated fascicle was used
as a control and implanted with a smaller diameter cuff electrode
(500 μm diameter) for recording and stimulation (Fig. 4b(II)). A
larger diameter periarterial cuff of approximately 6 mm diameter
was placed arounds the neurovascular bundle (Fig. 4b(I)). Sub-
sequently the tissue with the cuffs was moved into the recording
chamber containing circulated, oxygenated Kreb’s solution
34–36 °C. The stimulation cuffs were connected to a constant
current stimulator (DS5, Digitimer, UK) and the recording hook
electrodes were connected to a bioamplifier (BMA-400, CWE,
USA) (Fig. 4c, d). For stimulation, a bipolar configuration was
used to deliver monophasic pulses at 1 Hz. The neural signal was
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solution, and traced all along till the end of the sample, where the hooks are placed to record compound action potentials c (III), d Conceptual sketch of
tissue with the cuff, and hook placement, and e an example of eCAP observed on the oscilloscope.
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digitised through an ADC (Power-1401, CED, UK), stored on a
desktop computer and visualised on an oscilloscope (Fig. 4e).
Activation threshold was defined as the lowest stimulation level
that evoked a repeatedly visible eCAP above the background
noise in the recording. Maximum axon recruitment was assumed
at the point where the maximum eCAP was obtained.
The control isolated splenic fascicle demonstrated a mean
threshold of 1.5 mA with charge of 0.6 μC (0.4 ms pulse width),
and 100% recruitment at approximately 5 mA with charge of 2
μC (Supplementary Fig. 11). The mean activation thresholds for
pulse widths of 0.4 ms, 1 ms and 2 ms are approximately 25.6 ±
8.23 mA, 12.9 ± 4.29 mA and 7.4 ± 3.44 mA respectively (Fig. 5a).
The use of a 2 ms pulse width reduces the threshold by 2.5–3-fold,
for a 2.5-fold increase in pulse width from 0.4 ms to 2 ms. The
demographics of the stimulated human samples are presented in
Supplementary Table 3.
Nerve recruitment curves from individual donor samples at
different pulse widths of 0.4 ms, 1 ms and 2 ms are illustrated in
Fig. 5c, d and e respectively. Due to a maximum current output of
the External Pulse Generator (EPG) of 50 mA it was not possible
to reach 100% recruitment of nerves using a 0.4 ms pulse width
(as seen in Fig. 5c). Increasing the pulse width to 1 ms and 2 ms
pulse width was more favourable as a trade-off for reducing
current amplitude to complement the IPG output capabilities.
Estimated charge density requirements in human ex vivo samples
for 100% recruitment is <300 μC/cm2/phase (assuming 18 mm2
electrode surface area in this instance).
Importantly, the data obtained experimentally with the ex vivo
human tissue is consistent with the computational models. The
variation in threshold between the two approaches is approxi-
mately 15% for 1 ms and 2 ms and <20% for 0.4 ms pulse widths
(see Supplementary Table 4) validating the built human case
computational model. It is important to note that the maximum
amplitude of the eCAP may only approximately reflect the
maximum recruitment of all the axons because the ex vivo
measurements are heavily dependent on electrophysiology
method accuracy (signal to noise), whereas accuracy in the
computational modelling is dependent on accuracy of input
criteria. Despite these limitations, these platforms are widely used
approaches to evaluate nerve target engagement.
Simulated chronic charge requirements. Another significant
factor to consider while estimating the charge requirements in a
translational setting, is the impact of scar tissue formation
(encapsulation) over time in the electrical model. To study the
impact of fibrotic tissue ingrowth, and thereby mimicking a
chronic therapeutic implantation, we modified the computational
model to investigate the effect of scar tissue formation on
recruitment curves, stimulation thresholds and charge require-
ments. In this simulation we used FCS setup with 1 µm fibre
diameters. A 0.5 mm layer of scar tissue was positioned sur-
rounding the cuff, both within and outside of the cuff59. (Fig. 6,
Supplementary Fig. 12, ‘Method’ – Inclusion of Scar Tissue
Development). Charge requirements increased ~1.5 fold from an
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Fig. 5 Results from ex-vivo electrophysiological study of the human splenic samples. a Amplitude-Pulse width and Charge Density-Pulse width curves.
Charge density is estimated on the basis of 18 mm2 surface area of the cuff electrodes. b Comparative average recruitment curves for all the human sample
at three different pulse widths. For 0.4ms, the average excludes the samples in which 100% recruitment is not achieved. c–e Recruitment graphs from 0.4
ms, 1 ms and 2ms pulse widths. HT, human tissue, N= 9, Error bars represents range.
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acute to chronic encapsulated model for all pulse widths (Fig. 6a).
This is based on the assumption of a uniform shape of encap-
sulation around the electrode and the silicone (Supplementary
Fig. 12).
We investigated ways to mitigate the effect of encapsulation by
applying longer interphase delay. For a 1 ms pulse width, the
acute-chronic increase in charge requirements for 100 μs inter-
phase delay was found to be 47%; whereas increasing the
interphase delay to 200 μs mitigates the threshold increase to 35%
(Fig. 6b).
Finally, the findings from these simulations were combined
with the human ex vivo experimental data (Fig. 5) to understand
the approximate charge requirements over time. Applying the
1.5x factor to 1 ms and 2 ms human ex vivo data indicates the
requirement of ~50 μC for 100% recruitment of nerves (Fig. 6c).
Importantly, the findings from ex vivo and in silico provide
guidance on indicative stimulation dose parameters to de-risk
clinical trials. The relationship of these findings to in vivo
conditions i.e., the relationship between eCAP and organ
function, or the therapeutic efficacy will be presented in future
publications.
Discussions
This work provides first account of the neurostimulation para-
meters to our knowledge effective at activating nerves with the
human SNVB with the use of a circumferential cuff electrode.
Computational modelling and ex vivo human electrophysiology
studies had a significant impact in de-risking the clinical trans-
lation path and the definition of user requirements for the IPG.
The stimulation threshold in the ex vivo human study for 0.4 ms
pulse width was at least three times higher than the in vivo
porcine study (approx. 8 mA to 27 mA) [Donegà et al. (manu-
script under review)]. As seen in the pig, the stimulation
threshold is reduced in human samples when longer pulse widths
are used52. Longer pulse widths could be considered during IPG
and integrated circuit design as a way of achieving activation at
lower current amplitudes. Beyond 2-3 ms the charge benefit fol-
lows the rule of diminishing returns. Overall factors such as the
size of the SNVB, position of fascicles from the metal contact
pads, total metal coverage, and importantly cuff architecture
affects the electrical recruitment of nerves.
The range from ex vivo human, to their respective in silico
studies are found to be aligned within a <15% margin (Supple-
mentary Table 3, and Supplementary Fig. 4). A more detailed
physiological comparison between species can be found
here [Donegà et al. (manuscript under review)]. These models
can be further used to optimise numerous parameters such as cuff
designs, placement, IPG design and stimulation capabilities. In
this work, modelling analyses were performed for a single porcine
and human neurovascular bundle anatomy. To gain a more
comprehensive understanding of the relevant variability of the
human models it would be necessary to perform further analysis
for additional bundle anatomies. The use of a spatially extended
nerve model used in this study does not represent the full 3D
anatomical details of nerves, vessels, and surrounding tissues.
Fascicles and nerves can separate into lateral branches, include
tortuosity and curvature, and have variations in dimensions and
spatial distribution along the artery. These factors are not con-
sidered in the current models and offer opportunities for
refinement in future studies. Moreover, further computational
simulations could be performed to assess the demographic het-
erogeneity, potential dielectric variance of the neurovascular
bundle complex and pulsatile nature of the SNVB.
Computational and ex vivo models may also aid in evaluating
the likelihood of nerve damage. Nerve damage may result from
electric fields or electrochemical processes at the nerve-electrode
interface, depending on parameters including charge density60.
Histomorphometry and electrode design considerations suggest
that charge required for nerve activation in this study can be
safely applied to the SNVB. For example, distance between the
electrode surface and target nerves suggests that damage due to
charge density is unlikely to occur. A majority of the nerve fibres
in the SNVB are in the mid- to far-field location, particularly after
fibrotic encapsulation, reducing the likelihood of nerve damage60.
Furthermore, the results from this study suggest the upper range
charge density required to stimulate the SNVB surpasses the
known electrochemical limits of standard smooth platinum iri-
dium electrode61. Including high surface area treatments and
electrode coatings would increase the limit for stimulation,
enabling safer charge transfer to nerves62–64.
Ultimately these techniques, platforms, and studies are set out
to provide confidence in deriving requirement specifications for
the neural-electrode interface, and the compliance voltage and
output current within the chosen IPG. These have been studied to
define stimulation parameters to lead into chronic efficacy stu-
dies, and to help refine those prescribed within a first in human
intraoperative trial. The use of human tissue for in silico and
ex vivo neuromodulation refinement, are recommended as part of
the methodological arsenal for the refined design and verification
of clinically facing products.
Methods
Methods specific to experimental work
Histology. Human tissue was obtained from transplant organ donors and trans-
ported at 4 °C in UW (University of Wisconsin) organ preservation solution. The
tissue was immersed and fixed in 10% neutral buffered formalin (NBF) as soon as
possible post-excision. The samples were divided into sequential blocks of 0.5
cm–1.5 cm for histology (see Fig. 1b). The blocks were embedded in paraffin and
sectioned at 4–5 μm. The sections were stained with haematoxylin and eosin
(H&E). Glass slides were scanned at ×20 using an Aperio Digital Pathology Slide
Scanner (Leica Biosystems). The slides were analysed for histomorphometric
estimations using NDP viewer as an image analysis tool (Hamamatsu Photonics)65.
Fig. 6 Simulated charge requirements in chronic scenario. a, b Simulated chronic charge requirements in the human computational model with 0.5 mm
fibrotic tissue inside and outside of the cuff electrode. Acute and chronic comparison for pulse width 0.4ms, 1 ms and 2ms a, the effect of interphase delay
including 0ms, 0.1 ms (100 μs) and 0.2 ms (200 μs). c A simulated shift in human ex vivo data for 1 ms and 2ms pulse widths based on the average of the
collected ex-vivo data.
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Transmission electron microscopy. A cross section of human SNVB fixed in 10%
NBF was examined by Transmission Electron Microscopy. The tissue, divided into
sequential blocks, was post fixed with 1% osmium tetroxide and processed into
Agar 100 resin (Agar Scientific Ltd). Resin sections (1 μm thick), stained with
toluidine blue, were examined by light microscopy to determine the areas with
clear nerve fascicles. Subsequently, 90 nm thick sections were cut, stained with
UranyLess (TAAB Laboratories Equipment Ltd) and lead citrate and examined in a
Hitachi HT7700 transmission electron microscope. Images of nerve fascicles were
taken using Gatan OneView Digital Camera.
Cuff design. The cuff electrode is manufactured in silicone and composed of two
electrically active arms containing segmented stimulation electrodes and a flexible
electrical connection embedded in silicone.
Electrophysiology characterisation of human SNVB. Nerve activity in the human
electrophysiology study was continuously monitored using an oscilloscope, and
digitally recorded with a 1401 acquisition system and Spike 2 v8.0 software with a
sample rate set at 20 kHz. Evoked CAPs were averaged (8 pulses) and rectified for
quantification of area under the curve of the average response.
Methods specific to computational modelling
Image segmentation and modelling electrodes. A nerve cross section image for each
species was chosen from multiple histological images produced for histomorpho-
metric studies. The segmentation of nerve images by reconstructing the edges of
the relevant tissues was performed manually within Sim4Life48 for the porcine
model (ZMT Zurich MedTech AG, Zurich, Switzerland). The iSEG modeller was
used for automatic recognition of tissues in the human model, in order to identify
the principal tissues summarised in Table 1 in the next section with the exclusion
of the electrodes and the saline solution. Pre-processing of the image was executed
consisting of image-contrast enhancement. The tissue between the fascicles and the
electrode was identified as interfascicular tissue with different composition between
the two species (connective tissue for the porcine, and mixture of fat and con-
nective tissue for the human). Electrodes were created in Sim4Life using the CAD
functionality tools. The thickness of the perineurium was set to 3% of the fascicle
diameter in alignment with literature66.
Computational model generation. The Sim4Life platform was used to convert tissue
edges from the segmentation into surfaces, to extrude them along the z-axis to
develop the 3D bundle model, and to create the 3D models of the cuff electrodes.
Multiple variations of the SNVBs were initially created with different extrusion
length and dimensions of the surrounding saline solution to identify the minimal
dimension of the computational domain using EM simulations (see ‘Mesh Gen-
eration and Electromagnetic Simulation’). This was identified as the volume above
which the E-field is reduced from its maximum value (in proximity of the elec-
trodes) below at least −50 db. The criteria were applied to reduce the size of the
computational domain without affecting the calculation of the E-field distribution
and its influence on the neuroelectric activity of the axons.
Mesh generation and electromagnetic (EM) simulations. FEM EM simulations were
performed in Sim4Life using the Quasi-Static Ohmic Current Dominated67 (QS-
OCD) Finite Element Method (FEM) solver. It was used to solve the equation
∇σ∇φ ¼ 0, (where σ is the electric conductivity tensor, and φ the electric potential)
on adaptive unstructured meshes developed on the model geometries (bundle,
electrodes, saline). This solver was chosen as it permits to handle anisotropic
electric tensors conductivity and supports thin resistive layer modelling. It is
necessary for this study to efficiently model the endoneurium and the perineurium.
The use of the Ohmic-Current Dominated solver was justified by the validity of the
quasi-static condition σ  ε0εrω (where ε0 is the electric permeability of vacuum,
εr is the relative electric permeability of tissues and ω the angular frequency of the
EM field) for all the tissues (see ‘Dielectric Properties of Tissues’). This means that
system is only purely resistive and that capacitive effects are neglected.
Unstructured meshes mixing tetrahedral and prismatic elements generated with
adaptive sizes were built using the ‘Multidomain Meshing’ tool and optimised for
mesh quality. This permitted the fine sampling of the electric field and its gradients
even in very small structures (e.g., small fascicles). The meshes were edited to create
patches at the interfaces between fascicles and interfascicular tissue and at elec-
trode’s surfaces to assign electric flux density boundary conditions. The values were
assigned in A/m2 permitting an input current of 1 mA between the electrodes. The
final human and porcine meshes contained 20.4 M and 31.9 M mesh elements
respectively. EM simulations results were executed with high convergence criteria
and results were analysed in terms of electric (E-) and current density (J-) field map
distributions which were visualised as surface and vector plots.
Dielectric properties of tissue. Values of tissue dielectric properties - consisting only
the electric conductivity (σ)values - were assigned using the LF-IT’IS database68.
The conductivity values are reported in Table 1. All tissues and materials were
assumed isotropic and homogeneous with the exception of the endoneurium at
which anisotropic conductivity values were assigned (longitudinal component
parallel to the bundle’s axis).
Population of fascicles with axon trajectories. Python scripts were created to
automize each fascicle with 20 axonal trajectories (lines) extending the whole
fascicle’s length. This was done by creating a surface triangular mesh on each
fascicle’s cross section with an average element size of 1/10 of the smallest fascicle’s
axis and by identifying 20 random (x, y) coordinates of triangle centres as location
of the axonal trajectory.
C-fibre electrophysiological model. The Sundt49 electrophysiological model simu-
lating the basic neuro-electric activity of the membranes of unmyelinated C-fibres
axons according to the compartmental and cable representation was used in this
work. It consists of parameterised values of passive (membrane resistivity and
capacity, axial resistance) and active circuital parameters describing the dynamics
of axonal membrane. The model was implanted in the Sim4Life platform and its
code verified with respect to the original implementation (see ModelDB database,
access nr. 187473). The fibre has a specific membrane resistivity (Rm) of 10 kΩ/
cm2, an axial resistance (Ra) of 100Ωcm, and voltage-gated Na+ and delayed-
rectilinear K+ channels (KDR) at a density of 40 mS/cm2.
Coupled EM and neuronal simulations and threshold current quantification. Neu-
ronal electrophysiological simulations were executed for each axonal fibre in the
model parameterised as a C-fibre using the Yale’s NEURON solver69 integrated in
Sim4Life. The neuro-electric coupling was provided by the established ‘extracellular
mechanisms’ in NEURON that permits the insertion of the extracellular electric
potential φ field maps calculated by the EM simulations in the cable equation.
Transient simulations were executed in the regime of quasi-static approximation67
that permits the approximation of the instantaneous electric fields/potentials as the
product of E-fields/potential fields map and the (normalised) pulse shape. Simu-
lations provide simulated dynamics of relevant membrane electrophysiological
quantities such as the transmembrane electric potential Vm. Simulations were
executed with an integration time of 2.5 µs and for a duration of 5 ms, much longer
than the largest pulse duration (2 ms) for the sampling of a complete action
potential (AP) waveform. The threshold currents identified as the minimal input
current eliciting an AP were calculated for each axon in the neurovascular bundle.
This was done using an automatic titration procedure based on a bisection algo-
rithm that analyses profiles of transmembrane potentials for different input cur-
rents. APs were identified as spikes with depolarisation >80 mV with respect to the
resting potential. Recruitment curves were derived from titration tables by
cumulative approach.
Data processing (Python scripts). Python scripts were created to facilitate the
flexible, parametrised generation of functionalised nerve models, assignment of
heterogeneous tissue properties and anisotropic electrical conductivities, creation
of mesh and its editing, distribution of fibre models within fascicles, assignment of
electrophysiological behaviour and automised post-processing analysis. For
example, quantification of stimulation thresholds, extraction of recruitment curves,
identify location of spike initiation and latencies (time of first spikes) with respect
to stimulus pulse-shape. Python scripts were also created to calculate the surface
area of each fascicle’s cross section to inversely calculate the diameter of the
equivalent circle as d ¼ 2 ffiffiffiAp =π.
Sensitivity analysis. A sensitivity analysis was executed to verify the impact of the
variation the conductivity of the interfascicular tissue on the neuroelectric response
of axons, i.e., on location of spike initiation and thresholds. For the human the
extreme cases where the interfascicular tissue is associated with only fat (σ= 0.05
S/m) or only connective tissue (σ= 0.38 S/m) were considered. For each of this
tissue association, EM-neuronal simulations were executed, and thresholds and
recruitment curves calculated and compared.
Inclusion of scar tissue formation. In order to investigate the neurostimulation
properties (thresholds and recruitment curves) of the SNVBs during a hypothetical
Table 1 Dielectric properties of tissue.
Tissue σ [S/m]
Human Porcine
Endoneurium (tensor) σxx= σyy= 0.166, σzz= 0.57
Perineurium (thin layer) 8.7e–4m−1 (*diam[m])
Silicone 1e-16
Connective tissue 0.38
Fat 0.05
Vessel wall 0.232
Blood 0.666
Saline solution 2
Interfascicular tissue 0.205 0.38
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chronic implantation stage, the model geometry was modified to include a 0.5 mm
thick layer of scar tissue formation around the electrodes and silicone both within
and outside of the bundle (see Supplementary Fig. 12). Within the bundle, the scar
tissue formation was considered to replace all tissues with exception of the fascicles
whose number and positions were unchanged with respect to the acute phase
models shown in Fig. 2. Outside of the bundle, the scar tissue was considered to
replace a layer of saline solution. The scar tissue was considered isotropic and
heterogeneous for both the parts surrounding the electrode and the silicone. Three
values of scar tissue conductivities were considered, namely σscar= 0.15 S/m, 0.37 S/
m (as connective tissue) and 0.56 S/m. Highest value of conductivities were
extracted from measured scar tissue conductivities reported in59.
Ethical statement. All human tissue work was conducted in accordance with the
UK Human Tissue Authority Code of Practice and Human Tissue Act 2004.
Freshly explanted human splenic neurovascular tissue was obtained from organ
transplant donors after ethical approval and informed consent from the donor
families according to East of England – Cambridgeshire and Hertfordshire
Research Ethics Committee reference 16/EE/0227).
Pig tissue was provided by the Royal Veterinary College, Potters Bar, UK. All
animal tissue work was conducted in accordance with the Schedule 1 procedures of
the UK Animal (Scientific Procedures) Act 1986. The protocol for animal studies
was approved by the RVC Animal Welfare and Ethical Review Board and The
Galvani Animal and Scientific Review Committee. All animals were housed and
transported under conditions specified in the UK’s Animal Welfare Act 2006 and
The Welfare of Farm Animals (England) Regulations 2007.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data for Figs. 2, 5 and 6 are provided with the paper. Any other dataset is available
from the corresponding author upon reasonable request.
Received: 4 February 2020; Accepted: 15 September 2020;
References
1. Birmingham, K. et al. Bioelectronic medicines: a research roadmap. Nat. Rev.
Drug Discov. 13, 399 (2014).
2. Famm, K., Litt, B., Tracey, K. J., Boyden, E. S. & Slaoui, M. A jump-start for
electroceuticals. Nature 496, 159 (2013).
3. Katz, E. Implantable Bioelectronics. https://doi.org/10.1002/9783527673148
(Wiley, Weinheim, 2014).
4. Bronstein, J. M. et al. Deep brain stimulation for Parkinson disease: an expert
consensus and review of key issues. Arch. Neurol. 68, 165–171 (2011).
5. Deuschl, G. et al. A randomized trial of deep-brain stimulation for Parkinson’s
disease. N. Engl. J. Med. 355, 896–908 (2006).
6. North, R. B., Ewend, M. G., Lawton, M. T. & Piantadosi, S. Spinal cord
stimulation for chronic, intractable pain: superiority of “multi-channel”
devices. Pain 44, 119–130 (1991).
7. North, R. B., Kidd, D. H., Zahurak, M., James, C. S. & Long, D. M. Spinal cord
stimulation for chronic, intractable pain: experience over two decades.
Neurosurgery 32, 384–395 (1993).
8. North, R. B., Kidd, D. H., Farrokhi, F. & Piantadosi, S. A. Spinal cord
stimulation versus repeated lumbosacral spine surgery for chronic pain: a
randomized, controlled trial. Neurosurgery 56, 98–107 (2005).
9. Brindley, G. S., Polkey, C. E. & Rushton, D. N. Sacral anterior root stimulators
for bladder control in paraplegia. Spinal Cord. 20, 365 (1982).
10. Tanagho, E. A. & Schmidt, R. A. Electrical stimulation in the clinical
management of the neurogenic bladder. J. Urol. 140, 1331–1339 (1988).
11. Siegel, S. et al. Results of a prospective, randomized, multicenter study
evaluating sacral neuromodulation with InterStim therapy compared to
standard medical therapy at 6‐months in subjects with mild symptoms of
overactive bladder. Neurourol. Urodyn. 34, 224–230 (2015).
12. Ben-Menachem, E. Vagus-nerve stimulation for the treatment of epilepsy.
Lancet Neurol. 1, 477–482 (2002).
13. Morris, G. L. & Mueller, W. M. Long-term treatment with vagus nerve
stimulation in patients with refractory epilepsy. Neurology 53, 1731
(1999).
14. Labiner, D. M. & Ahern, G. L. Vagus nerve stimulation therapy in depression
and epilepsy: therapeutic parameter settings. Acta Neurol. Scand. 115, 23–33
(2007).
15. Rush, A. J. et al. Vagus nerve stimulation for treatment-resistant depression: a
randomized, controlled acute phase trial. Biol. Psychiatry 58, 347–354 (2005).
16. Valentin, P. & Kevin, T. The vagus nerve and the inflammatory reflex—
linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743–754 (2012).
17. Tracey, K. J. The inflammatory reflex. Nature 420, 853–859 (2002).
18. Waltz, E. Erratum: a spark at the periphery. Nat. Biotechnol. 34, 1292–1292
(2016).
19. Koopman, F. A. et al. Vagus nerve stimulation inhibits cytokine production
and attenuates disease severity in rheumatoid arthritis. Proc. Natl Acad. Sci.
USA 113, 8284–8289 (2016).
20. Garamendi-Ruiz, I. & Gómez-Esteban, J. C. Cardiovascular autonomic effects
of vagus nerve stimulation. Clin. Auton. Res. 29, 183–194 (2019).
21. Kreuzer, P. M. et al. Transcutaneous vagus nerve stimulation: retrospective
assessment of cardiac safety in a pilot study. Front. Psychiatry 3, 70 (2012).
22. Åmark, P., Stödberg, T. & Wallstedt, L. Late onset bradyarrhythmia during
vagus nerve stimulation. Epilepsia 48, 1023–1024 (2007).
23. Ben-Menachem, E. Vagus nerve stimulation, side effects, and long-term safety.
J. Clin. Neurophysiol. 18, 415–418 (2001).
24. Ben-Menachem, E. & French, J. A. VNS Therapy versus the latest antiepileptic
drug. Epileptic Disord. 7, 22–26 (2005).
25. Cristancho, P., Cristancho, M. A., Baltuch, G. H., Thase, M. E. & O’Reardon, J.
P. Effectiveness and safety of vagus nerve stimulation for severe treatment-
resistant major depression in clinical practice after FDA approval: outcomes at
1 year. J. Clin. Psychiatry 72, 1376–1382 (2011).
26. Lange, G. et al. Safety and efficacy of vagus nerve stimulation in fibromyalgia:
a phase I/II proof of concept trial. Pain. Med. 12, 1406–1413 (2011).
27. Pikov, V., Sridhar, A. & Lara, H. E. High-frequency electrical modulation of
the superior ovarian nerve as a treatment of polycystic ovary syndrome in the
rat. Front. Physiol. 9, 1–8 (2018).
28. Ribeiro, M. J. et al. Carotid body denervation prevents the development of
insulin resistance and hypertension induced by hypercaloric diets. Diabetes 62,
2905–2916 (2013).
29. Patel, Y. A., Saxena, T., Bellamkonda, R. V. & Butera, R. J. Corrigendum:
Kilohertz frequency nerve block enhances anti-inflammatory effects of vagus
nerve stimulation. Sci. Rep. 7, 46848 (2017).
30. Guyot, M. et al. Apical splenic nerve electrical stimulation discloses an anti-
inflammatory pathway relying on adrenergic and nicotinic receptors in
myeloid cells. Brain. Behav. Immun. https://doi.org/10.1016/j.bbi.2019.03.015
(2019).
31. Vervoordeldonk, M. et al. Treatment of disorders associated with inflammation.
https://patents.google.com/patent/WO2019122908A1/en?inventor=Isha+
gupta&assignee=Galvani+Bioelectronics+Limited&language=ENGLISH
(2018).
32. Bioelectronics, G. Feasibility of Splenic Nerve Stimulation During
Esophagectomy. November 28, 2019 Available at: https://clinicaltrials.gov/ct2/
show/NCT04171011.
33. Woodbury, D. M. & Woodbury, J. W. Effects of vagal stimulation on
experimentally induced seizures in rats. Epilepsia 31, S7–S19 (1990).
34. Alexander, R. Lessons learned from the fate of AstraZeneca’s drug pipeline: a
five-dimensional framework. Nat. Publ. Gr. https://doi.org/10.1038/nrd4309
(2014).
35. Fogel, D. B. Factors associated with clinical trials that fail and opportunities
for improving the likelihood of success: a review. Contemp. Clin. Trials
Commun. 11, 156–164 (2018).
36. Pammolli, F., Magazzini, L. & Riccaboni, M. The productivity crisis in
pharmaceutical R&D. Nat. Rev. Drug Discov. 10, 428 (2011).
37. Rattay, F. Analysis of models for external stimulations of axons. IEEE Trans.
Biomed. Eng. 10, 974–977 (1986).
38. Choi, A. Q., Cavanaugh, J. K. & Durand, D. M. Selectivity of multiple-contact
nerve cuff electrodes: a simulation analysis. IEEE Trans. Biomed. Eng. 48,
165–172 (2001).
39. Lago, N. et al. A critical review of interfaces with the peripheral nervous
system for the control of neuroprostheses and hybrid bionic systems. J.
Peripher. Nerv. Syst. 10, 229–258 (2005).
40. Schiefer, M. A., Polasek, K. H., Triolo, R. J., Pinault, G. C. J. & Tyler, D. J.
Selective stimulation of the human femoral nerve with a flat interface nerve
electrode. J. Neural Eng. 7, 26006 (2010).
41. Schiefer, M. A., Triolo, R. J. & Tyler, D. J. A model of selective activation of the
femoral nerve with a flat interface nerve electrode for a lower extremity
neuroprosthesis. IEEE Trans. Neural Syst. Rehabil. Eng. 46, 220–231 (2010).
42. Schiefer, M. A., Tyler, D. J. & Triolo, R. J. Probabilistic modeling of selective
stimulation of the human sciatic nerve with a flat interface nerve electrode. J.
Comput. Neurosci. 33, 179–190 (2012).
43. Pelot, N. A., Behrend, C. E. & Grill, W. M. On the parameters used in finite
element modeling of compound peripheral nerves. J. Neural Eng. 16, 16007
(2018).
44. Musselman, E. D., Pelot, N. A. & Grill, W. M. Empirically based guidelines for
selecting vagus nerve stimulation parameters in epilepsy and heart failure.
Cold Spring Harb. Perspect. Med. 9, a034264 (2019).
ARTICLE COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-01299-0
10 COMMUNICATIONS BIOLOGY |           (2020) 3:577 | https://doi.org/10.1038/s42003-020-01299-0 | www.nature.com/commsbio
45. Kimmelman, J. & Federico, C. Consider drug efficacy before first-in-human
trials. Nature 542, 25 (2017).
46. Quester, R. & Schröder, R. The shrinkage of the human brain stem during
formalin fixation and embedding in paraffin. J. Neurosci. Methods 75, 81–89
(1997).
47. Ciorsac, A., Craciun, D., Ostafe, V. & Isvoran, A. Nonlinear correlations in the
hydrophobicity and average flexibility along the glycolytic enzymes sequences.
Chaos Solitons Fractals 44, 191–197 (2011).
48. Neufeld, E., Gosselin, M. C., Sczcerba, D., Zefferer, M. & Kuster, N. Sim4Life:
A Medical Image Data Based Multiphysics Simulation Platform for
Computational Life Sciences (2012).
49. Sundt, D., Gamper, N. & Jaffe, D. B. Spike propagation through the dorsal root
ganglia in an unmyelinated sensory neuron: a modeling study. J. Neurophysiol.
114, 3140–3153 (2015).
50. Ordonez, J. S. et al. Cuff electrodes for very small diameter nerves —
Prototyping and first recordings in vivo. In 2014 36th Annual International
Conference of the IEEE Engineering in Medicine and Biology Society
6846–6849. https://doi.org/10.1109/EMBC.2014.6945201 (2014).
51. Garai, P., Koh, R. G. L., Schuettler, M., Stieglitz, T. & Zariffa, J. Influence of
anatomical detail and tissue conductivity variations in simulations of multi-
contact nerve cuff recordings. IEEE Trans. Neural Syst. Rehabil. Eng. 25,
1653–1662 (2017).
52. Lucas, K. On the rate of variation of the exciting current as a factor in electric
excitation. J. Neurophysiol. 36, 253–274 (1907).
53. Reilly, J. P., Freeman, V. T. & Larkin, W. D. Sensory effects of transient
electrical stimulation - evaluation with a neuroelectric model. IEEE Trans.
Biomed. Eng. BME-32, 1001–1011 (1985).
54. Demosthenous, A. Advances in microelectronics for implantable medical
devices. Adv. Electron. 2014 (2014).
55. Ward, C., Henderson, S. & Metcalfe, N. H. A short history on pacemakers ☆.
Int. J. Cardiol. 169, 244–248 (2013).
56. Liu, X., Demosthenous, A. & Donaldson, N. An integrated implantable
stimulator that is fail-safe without off-chip bloacking capacitors. IEEE Trans.
Biomed. Circuits Syst. 2, 231–244 (2008).
57. Langlois, P. J., Demosthenous, A., Member, S. & Pachnis, I. High-power
integrated stimulator output stages with floating discharge over a wide voltage
range for nerve stimulation. IEEE Trans. Biomed. Circuits Syst. 4, 39–48
(2010).
58. Jiang, D. et al. A Stimulator ASIC featuring versatile management for
vestibular prostheses. IEEE Trans. Biomed. Circuits Syst. 5, 147–159
(2011).
59. Grill, W. M. & Thomas, J. Electr. Prop. Implant Encapsulation Tissue 22,
23–33 (1994).
60. Cogan, S. F., Ludwig, K. A., Welle, C. G. & Takmakov, P. Tissue damage
thresholds during therapeutic electrical stimulation. J. Neural Eng. 13, 021001
(2016).
61. Rose, T. L. & Robblee, L. S. Electrical stimulation with Pt electrodes. VIII.
Electrochemically safe charge injection limits with 0.2 MS pulses. IEEE Trans.
Biomed. Eng. 37, 1118–1120 (1990).
62. Park, H., Takmakov, P. & Lee, H. Electrochemical evaluations of fractal
microelectrodes for energy efficient neurostimulation. Sci. Rep. 8, 1–11 (2018).
63. Cogan, S. F. Neural stimulation and recording electrodes. Annu. Rev. Biomed.
Eng. 10, 275–309 (2008).
64. Won, S. M. et al. Recent advances in materials, devices, and systems for neural
interfaces. Adv. Mater. 30, 1800534 (2018).
65. HAMAMATSU - PHOTON IS OUR BUSINESS. Image Viweing Sofware,
NDP.view2. 2–3
66. Grinberg, Y., Schiefer, M. A., Tyler, D. J. & Gustafson, K. J. Fascicular
perineurium thickness, size, and position affect model predictions of neural
excitation. IEEE Trans. Neural Syst. Rehabil. Eng. 16, 572–581 (2008).
67. Bossetti, C. A., Birdno, M. J. & Grill, W. M. Analysis of the quasi-static
approximation for calculating potentials generated by neural stimulation. J.
Neural Eng. 5, 44–53 (2008).
68. Hasgall, P. et al. IT’IS Database for thermal and electromagnetic parameters of
biological tissues. Version 4.0, May 15, 2018. https://doi.org/10.13099/
VIP21000-04-0.
69. Carnevale, N. T. & Hines, M. L. The NEURON Book Chapter 4. NEURON B.
1–38 (2004).
Acknowledgements
The authors thank Karen Cartwright and Nicola McCormack at GlaxoSmithKline (UK)
for processing the tissue for histology. We thank Dr. Kourosh Saeb-Parsy, Nikola
Dolezalova, Krishnaa Mahbubani at Addenbrooke’s hospital (Cambridge, UK) for dis-
secting and providing valuable human tissue. The authors are also grateful for the
generous donation of post-mortem human tissue by fourteen anonymous individuals.
We further thank Cindy Au at Verily Life Sciences for providing CAD designs of cuff
electrodes for computational modelling.
Author contributions
I.G., J.W. and D.J.C. designed the study. A.R., I.G., P.G. and K.C. performed the histo-
pathological and data analysis studies from human tissue samples. I.G., M.D., D.M.S.,
W.D. and J.A.M. performed the human ex vivo electrophysiological study. I.G. analysed
the data. I.G., A.M.C., M.A.S., I.T., E.N. and N.K. executed and analysed the computa-
tional models. S.O., P.M. and R.F.Y. contributed to designing the cuff electrode. K.S.P.
and N.D. provided the precious human samples for histology and ex vivo work. J.P.
provided valuable pig tissue. I.G., A.C. and D.J.C. wrote the manuscript. All authors
contributed in reviewing the manuscript.
Competing interests
I.G., M.D., D.M.S., J.A.M., D.J.C., S.O., P.M., W.D., R.F.Y. and J.W. are employees of
Galvani Bioelectronics and declare that Galvani Bioelectronics has filed international
patent applications describing methods, devices, and systems for splenic nerve neuro-
modulation. We declare that Galvani Bioelectronics provided funds to support their work
associated with this manuscript. A.M.C., E.N., N.K., J.P., K.S.P., N.D. and M.A.S. declare
that Galvani Bioelectronics provided funds to support their work associated with this
manuscript. The remaining authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s42003-
020-01299-0.
Correspondence and requests for materials should be addressed to I.G. or D.J.C.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-01299-0 ARTICLE
COMMUNICATIONS BIOLOGY |           (2020) 3:577 | https://doi.org/10.1038/s42003-020-01299-0 | www.nature.com/commsbio 11
